Geneart

In Brief This Week is a column containing news items that our readers may have missed during the week.

The firm, which now majority-owned by Life Technologies, also posted a sharp gain in its earnings before interest and taxes.

Life Tech now owns 74 percent of the synthetic gene company.

Life Technologies has made a tender offer to acquire the remaining shares of Geneart that it does not already own for around €25.5 million. The total purchase price was approximately €56 million.

The agreement gives Applied Biosystems Deutschland approximately 58 percent of GeneArt's shares.

A proposed HHS guidance for synthetic biology roughly fits a harmonization effort started by the International Gene Synthesis Consortium.

Five firms have formed the International Gene Synthesis Consortium to set gene and customer screening protocols that address security concerns.

The firm's sales increased despite the expiration of an NIH contract.

John Mendelsohn, a former president of the University of Texas MD Anderson Cancer Center, has died, the New York Times reports.

Chinese state news agency Xinhua reports that a preliminary investigation has found He Jiankui performed his gene-editing work illegally.

Identical twins receive different estimates of ancestry from the same direct-to-consumer genetic testing firms, CBC reports.

In PNAS this week: chromosomal features of maize, adaptations in the vinous-throated parrotbill, and more.